Comparing total and reverse shoulder arthroplasty for shoulder osteoarthritis in older adults
Official title: Study Evaluating Reverse Versus Anatomic Shoulder Arthroplasty Techniques in the Treatment of Osteoarthritis: Protocol
Run by Ottawa Hospital Research Institute · NCT04228419 · Data updated 2026-11-12
This study is testing whether total shoulder surgery or reverse shoulder surgery works better for older adults with shoulder arthritis who haven't found relief from other treatments.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 108 (estimated) |
| Sponsor | Ottawa Hospital Research Institute Academic / other |
| Locations | 4 sites (Edmonton, Alberta and 3 other locations) |
| Status | Recruiting |
| Started | March 9, 2020 |
| Main results expected | January 1, 2030 |
| Study ends | December 31, 2032 |
| Registry record updated | March 25, 2025 |
| Trial ID | NCT04228419 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients aged 65 and older who have failed non-surgical management for their shoulder osteoarthritis and have specific anatomical criteria.
✕Probably not a fit
Patients with active joint infections, significant muscle paralysis, or major medical illnesses may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to compare total shoulder arthroplasty (TSA) and reverse shoulder arthroplasty (RSA) procedures in patients aged 65 and older with glenohumeral osteoarthritis. The study will involve a prospective, randomized-controlled design to assess which surgical approach provides better outcomes for patients with specific anatomical considerations, such as glenoid retroversion. By evaluating the effectiveness and safety of these two surgical options, the research seeks to provide valuable insights for surgeons treating this aging population. The trial will include patients who have not responded to standard non-surgical management for their shoulder condition.
Why it matters
Potential benefit: If successful, this study could help identify the most effective surgical treatment for older patients suffering from shoulder osteoarthritis, potentially improving their quality of life.
How similar studies have gone: While few studies have directly compared TSA and RSA in this specific older population, existing literature suggests that RSA has shown promising outcomes in similar cases, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients who have failed standard non-surgical management of their idiopathic shoulder osteoarthritis who would benefit from a shoulder arthroplasty. Failed medical management will be defined as persistent pain and disability despite adequate standard non-operative management for 6 months. Medical management will be defined as: 1. The use of drugs including analgesics and non-steroidal anti-inflammatory drugs 2. Physiotherapy consisting of stretching, strengthening and local modalities (ultrasound, cryotherapy, etc.) 3. Activity modification 2. Imaging, and intra-operative findings confirming advanced glenohumeral cartilage loss 3. Patients may present with a glenoid deficiency and \</=15 degrees of retroversion 4. 65 years of age and older Exclusion Criteria: 1. Active joint or systemic infection 2. Rotator cuff arthropathy 3. Significant muscle paralysis 4. Charcot's arthropathy 5. Major medical illness (life expectancy less than 1 year or unacceptably high operative risk) 6. Unable to understand the consent form/process 7. Pregnancy 8. Psychiatric illness that precludes informed consent 9. Unwilling to be followed for the duration of the study 10. Retroversion cannot be surgically corrected to within 10 degrees of neutral 11. History of previous shoulder surgery on affected side
Where it's running
-
Kingston General Hospital (Site-Watkins 3)
Kingston, Ontario, Canada Recruiting -
The Ottawa Hospital
Ottawa, Ontario, Canada Recruiting -
University of Alberta
Edmonton, Alberta, Canada Not yet recruiting -
Pan Am Clinic Foundation
Winnipeg, Manitoba, Canada Not yet recruiting
Study contacts
- Principal investigator: Peter Lapner, MD — The Ottawa Hospital
- Study coordinator: Peter Lapner Lapner, MD
- Email: plapner@toh.ca
- Phone: 613-737-8899
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing shoulder function of two implant systems for osteoarthritis
This study is testing whether a new shoulder implant helps people with osteoarthritis recover and function better after surgery compared to a standard implant.
-
One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital
A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.
-
Blood Transfusion Thresholds During Major Surgery
This study tests whether a higher versus lower blood transfusion threshold during surgery helps reduce serious complications or death after major surgery.
-
Brain scans to find links between brain activity and knee replacement outcomes
This study uses brain MRI before and after knee replacement to see if patterns of brain activity can predict which patients will be satisfied with their surgery.
-
Safety of perioperative blood thinner management in people with cancer undergoing surgery or procedures
This study tests how safe current practices are for stopping or continuing blood thinners in adults with cancer who are having surgery or procedures, to see if bleeding or clots are affected.
-
Morning versus evening timing of hormone therapy for metastatic breast and prostate cancer
This pilot will test whether taking hormone-based cancer drugs in the morning or in the evening works better for people with metastatic breast or prostate cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.